- Home
- LQDA vs CNOB Comparison
LQDA vs CNOB Comparison
Compare LQDA & CNOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LQDA
- CNOB
- Stock Information
- Founded
- LQDA 2004
- CNOB 1982
- Country
- LQDA United States
- CNOB United States
- Employees
- LQDA N/A
- CNOB N/A
- Industry
- LQDA Biotechnology: Pharmaceutical Preparations
- CNOB Major Banks
- Sector
- LQDA Health Care
- CNOB Finance
- Exchange
- LQDA Nasdaq
- CNOB Nasdaq
- Market Cap
- LQDA 1.2B
- CNOB 1.2B
- IPO Year
- LQDA 2018
- CNOB 1996
- Fundamental
- Price
- LQDA $19.60
- CNOB $24.25
- Analyst Decision
- LQDA Strong Buy
- CNOB Buy
- Analyst Count
- LQDA 9
- CNOB 1
- Target Price
- LQDA $27.67
- CNOB $31.00
- AVG Volume (30 Days)
- LQDA 2.4M
- CNOB 310.7K
- Earning Date
- LQDA 08-06-2025
- CNOB 07-29-2025
- Dividend Yield
- LQDA N/A
- CNOB 2.97%
- EPS Growth
- LQDA N/A
- CNOB N/A
- EPS
- LQDA N/A
- CNOB 1.84
- Revenue
- LQDA $14,144,000.00
- CNOB $256,824,000.00
- Revenue This Year
- LQDA $189.27
- CNOB $45.61
- Revenue Next Year
- LQDA $402.79
- CNOB $30.74
- P/E Ratio
- LQDA N/A
- CNOB $13.18
- Revenue Growth
- LQDA N/A
- CNOB 1.84
- 52 Week Low
- LQDA $8.26
- CNOB $20.08
- 52 Week High
- LQDA $19.76
- CNOB $29.31
- Technical
- Relative Strength Index (RSI)
- LQDA 79.39
- CNOB 49.26
- Support Level
- LQDA $14.04
- CNOB $24.43
- Resistance Level
- LQDA $14.67
- CNOB $25.32
- Average True Range (ATR)
- LQDA 0.89
- CNOB 0.55
- MACD
- LQDA 0.70
- CNOB -0.11
- Stochastic Oscillator
- LQDA 97.88
- CNOB 27.81
About LQDA Liquidia Corporation
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.
About CNOB ConnectOne Bancorp Inc.
ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental and consumer wages.